Tweets
Registry data suggests an increased risk of herpes zoster (HZ, shingles) in rheumatoid arthritis (RA) patients taking JAK inhibitors (JAKi) but also with other biologic DMARDs, compared to csDMARDs.
https://t.co/Uu1VjAbKMi https://t.co/uGvTyLExjf
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
The ARTIS Study Group has published their analysis of (non-skin) cancer risk in rheumatoid arthritis, claiming the overall safety of biologic DMARDs and targeted synthetic DMARDs (tsDMARDs).
https://t.co/RNWrLR53Wx https://t.co/mMmKKrX9vx
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Health personnel (HCP) @ long-term care facilities (LTCFs) are at high risk for COVID-19. March 2021, 57% of LTCF HCPs were vaccinated. COVID-19 vax was highest in MDs (75.1%); lowest nurses (56.7%) & aides (45.6%). https://t.co/VjHutcrh26 https://t.co/8aO1mFgC8f
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI: The FDA has authorized baricitinib ALONE as treatment for COVID-19 hospitalized adults and pediatric patients requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) https://t.co/WMc78GmOLU https://t.co/Bp5tL4pRk5
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Worth another share--
Turning the Corner on CV Risk in Rheumatoid Arthritis by Richard Conway ( @RichardPAConway) #EULAR2021
https://t.co/S0ownscRKv https://t.co/7QtynRKAd6
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI: One of our top June videos
WATCH: Is blindness with Tocilizumab in GCA a worry?
Dr. David Liew ( @drdavidliew ) weighs in. #EULAR2021
https://t.co/eFrmbkW9Gy https://t.co/4tY3hEDj2j
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Pain Persists in RA, Even Without Inflammation
One-third of patients with rheumatoid arthritis had unacceptably high levels of pain 5 years after diagnosis, often despite low levels of inflammation, Swedish researchers found.
https://t.co/K8zf1pE9jM https://t.co/aEBu7jVHft
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
RheumNow Podcast – Psoriatic Arthritis Without Psoriasis
Download wherever you get your podcasts!
https://t.co/Ra5f7507XT https://t.co/5WqPCgGVpr
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Did you see this tweet from May? Worth re-sharing.
Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris. One year study of 135 moderate-to-severe pemphigus patients saw complete remission in 40% of RTX vs 10% of MMF patients. https://t.co/yAauFRjHCe https://t.co/bibHXaHtWf
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
New podcast available for download! We focus on the articles shared this week on https://t.co/V10S4oVFsv .
https://t.co/Ra5f7507XT https://t.co/Pz0RFxLIOx
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Swiss SCQM registry compared 3217 RA & 819 PsA pts; PsA had more obese (36.5% overweight, 23.8% obese) than RA (4.4% underweight, 31.8% overweight, 17.0% obese). Obese PsA had higher CRP, Dz activity, worse QOL, pain & skin https://t.co/UzbKlT3tSz
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
